NDC11 50458056403
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50458-0564-03 | 50458-0564 |
| 50458-0564-3 | 50458-0564 |
| 50458-564-03 | 50458-564 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INVEGA SUSTENNA | PALIPERIDONE PALMITATE | Janssen Pharmaceuticals, Inc. | 1af14e42-951d-414d-8564-5d5fce138554 | 2025-02-14 | Boxed warning, Warnings, Adverse reactions | 50458-564-03 50458-564 50458056403 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.